Eric N.P. Subong

2.4k total citations · 2 hit papers
19 papers, 1.8k citations indexed

About

Eric N.P. Subong is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Molecular Biology. According to data from OpenAlex, Eric N.P. Subong has authored 19 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 7 papers in Rheumatology and 4 papers in Molecular Biology. Recurrent topics in Eric N.P. Subong's work include Prostate Cancer Diagnosis and Treatment (14 papers), Prostate Cancer Treatment and Research (12 papers) and Urologic and reproductive health conditions (7 papers). Eric N.P. Subong is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (14 papers), Prostate Cancer Treatment and Research (12 papers) and Urologic and reproductive health conditions (7 papers). Eric N.P. Subong collaborates with scholars based in United States. Eric N.P. Subong's co-authors include Alan W. Partin, Paula C. Southwick, Gail H. Gasior, William J. Catalona, Patrick C. Walsh, Jean B. deKernion, Kevin M. Slawin, Robert E. Parson, Kathleen G Loveland and Robert C. Flanigan and has published in prestigious journals such as JAMA, Ophthalmology and The Journal of Urology.

In The Last Decade

Eric N.P. Subong

19 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease

1998 860 citations William J. Catalona, Alan W. Partin et al. JAMA profile →
Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab

2020 227 citations Caroline R. Baumal, Richard F. Spaide et al. Ophthalmology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric N.P. Subong United States	13	1.3k	387	383	213	208	19	1.8k
Christian Eichelberg Germany	21	999 0.8×	178 0.5×	582 1.5×	5 0.0×	246 1.2×	67	1.4k
Robert F. Hoedemaeker Netherlands	26	1.6k 1.3×	433 1.1×	222 0.6×	5 0.0×	434 2.1×	46	2.0k
Jerry J.J. Yuan United States	6	1.6k 1.3×	539 1.4×	360 0.9×	3 0.0×	573 2.8×	8	2.2k
Corinna Wittmer Germany	18	602 0.5×	128 0.3×	392 1.0×	5 0.0×	110 0.5×	28	984
Daniel Petrylak United States	6	1.9k 1.5×	45 0.1×	453 1.2×	29 0.1×	236 1.1×	8	2.4k
Claudia Kesch Germany	24	2.0k 1.6×	619 1.6×	113 0.3×	5 0.0×	229 1.1×	81	2.5k
Daphne Hessels Netherlands	23	2.3k 1.9×	269 0.7×	1.7k 4.3×	5 0.0×	340 1.6×	48	3.5k
Ronald Tutrone United States	21	1.1k 0.9×	273 0.7×	426 1.1×	3 0.0×	132 0.6×	111	1.7k
Michelle R. Downes Canada	21	666 0.5×	143 0.4×	397 1.0×	3 0.0×	398 1.9×	77	1.3k
Francesca Giunchi Italy	23	809 0.6×	141 0.4×	357 0.9×	3 0.0×	451 2.2×	105	1.5k

Countries citing papers authored by Eric N.P. Subong

Since Specialization

Citations

This map shows the geographic impact of Eric N.P. Subong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric N.P. Subong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric N.P. Subong more than expected).

Fields of papers citing papers by Eric N.P. Subong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric N.P. Subong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric N.P. Subong. The network helps show where Eric N.P. Subong may publish in the future.

Co-authorship network of co-authors of Eric N.P. Subong

This figure shows the co-authorship network connecting the top 25 collaborators of Eric N.P. Subong. A scholar is included among the top collaborators of Eric N.P. Subong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric N.P. Subong. Eric N.P. Subong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

1.

Baumal, Caroline R., Richard F. Spaide, Lejla Vajzovic, et al.. (2020). Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab. Ophthalmology. 127(10). 1345–1359. 227 indexed citations breakdown →

2.

Subong, Eric N.P., et al.. (1999). Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23. The Prostate. 39(4). 298–304. 98 indexed citations

3.

deKernion, Jean B., et al.. (1999). Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease. The Journal of Urology. 353–354. 5 indexed citations

4.

Catàlona, William J., Alan W. Partin, Kevin M. Slawin, et al.. (1999). Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease: A Prospective Multicenter Clinical Trial. The Journal of Urology. 161(1). 353–354. 59 indexed citations

5.

Subong, Eric N.P., et al.. (1999). Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4‐216) recognizes nucleophosmin/B23. The Prostate. 39(4). 298–304. 2 indexed citations

6.

Catalona, William J., Alan W. Partin, Kevin M. Slawin, et al.. (1998). Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease. JAMA. 279(19). 1542–1542. 860 indexed citations breakdown →

7.

Marks, L., Alan W. Partin, Glenn J. Gormley, et al.. (1998). RE: PROSTATE TISSUE COMPOSITION AND RESPONSE TO FINASTERIDE IN MEN WITH SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA. The Journal of Urology. 160(1). 134–134. 2 indexed citations

8.

Lakshmanan, Yegappan, Eric N.P. Subong, & Alan W. Partin. (1998). DIFFERENTIAL NUCLEAR MATRIX PROTEIN EXPRESSION IN PROSTATE CANCERS: CORRELATION WITH PATHOLOGIC STAGE. The Journal of Urology. 159(4). 1354–1358. 24 indexed citations

9.

Pannek, Jürgen, Leonard S. Marks, Jay D. Pearson, et al.. (1998). INFLUENCE OF FINASTERIDE ON FREE AND TOTAL SERUM PROSTATE SPECIFIC ANTIGEN LEVELS IN MEN WITH BENIGN PROSTATIC HYPERPLASIA. The Journal of Urology. 159(2). 449–453. 44 indexed citations

10.

Pannek, Jürgen, Harry G. Rittenhouse, Cindy L. Evans, et al.. (1997). Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer. Urology. 50(5). 715–721. 33 indexed citations

11.

Partin, Alan W., Joseph V. Briggman, Eric N.P. Subong, et al.. (1997). Preliminary immunohistochemical characterization of a monoclonal antibody (pro:4-216) prepared from human prostate cancer nuclear matrix proteins. Urology. 50(5). 800–808. 22 indexed citations

12.

Marks, Leonard S., Alan W. Partin, Glenn J. Gormley, et al.. (1997). Prostate Tissue Composition and Response to Finasteride in Men With Symptomatic Benign Prostatic Hyperplasia. The Journal of Urology. 2171–2178. 3 indexed citations

13.

Marks, Leonard S., Alan W. Partin, Glenn J. Gormley, et al.. (1997). Prostate Tissue Composition and Response to Finasteride in Men With Symptomatic Benign Prostatic Hyperplasia. The Journal of Urology. 157(6). 2171–2178. 65 indexed citations

14.

Pannek, Jürgen, Eric N.P. Subong, Penny Marschke, et al.. (1996). The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer. Urology. 48(6). 51–54. 52 indexed citations

15.

Partin, Alan W., Steven Piantadosi, Eric N.P. Subong, et al.. (1996). Clearance rate of serum-free and total PSA following radical retropubic prostatectomy. The Prostate. 29(S7). 35–39. 33 indexed citations

16.

Partin, Alan W., et al.. (1996). Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total psa, prostate volume, and age. Urology. 48(6). 55–61. 211 indexed citations

17.

Partin, Alan W., Stuart R. Criley, Eric N.P. Subong, et al.. (1996). Standard Versus Age-Specific Prostate Specific Antigen Reference Ranges Among Men With Clinically Localized Prostate Cancer: A Pathological Analysis. The Journal of Urology. 155(4). 1336–1339. 68 indexed citations

18.

Partin, Alan W., Stuart R. Criley, Eric N.P. Subong, et al.. (1996). Standard Versus Age-Specific Prostate Specific Antigen Reference Ranges Among Men With Clinically Localized Prostate Cancer. The Journal of Urology. 1336–1339. 1 indexed citations

19.

Partin, Alan W., Steven Piantadosi, Eric N.P. Subong, et al.. (1996). Clearance rate of serum‐free and total PSA following radical retropubic prostatectomy. The Prostate. 29(S7). 35–39. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact